24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Principle of Sovereign Immunity
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
22:27
Five months old, Noetive raises $41 million Seed to build AI for the physical economy
20:39
The man who helped build Palo Alto’s Cortex is leaving the company
20:20
Wiz founders Rappaport and Costica add television to their post-exit portfolio with $120 million Reshet 13 deal
17:12
Israel’s tech exports hit a record but foreign owners are claiming more of the gains
More stories
Buzz
Most popular
Daily
Weekly
1
How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit
2
Oracle is expanding layoffs but its new CFO says “don’t do more with less”
3
The ThinkPad X13 is almost boring, and that’s exactly the point
4
Buildots raises $130 million at nearly $1 billion valuation as AI boom drives data center construction
5
Former Mossad chief Yossi Cohen joins Israeli quantum tech company Quantum X Labs
More news
Principle of Sovereign Immunity
1 stories about Principle of Sovereign Immunity
Court Rules Allergan Can't Use Indian Tribe Deal to Protect Patents
23.07.18
|
CTech
In September 2017, Allergan transferred six of its patents for blockbuster dry eye drug Restasis to the St. Regis Mohawk Tribe, hoping to protect the patents under the principle of sovereign immunity